Graham Capital Management’s Boston Scientific BSX Stock Holding History

Graham Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,561	Closed	-$2.44M	–	1192
2025 Q4	$2.44M	Sell	25,561 -40,679	-61%	-$3.99M	0.06%	210
2025 Q3	$6.47M	Sell	66,240 -113,835	-63%	-$11.8M	0.1%	92
2025 Q2	$19.3M	Buy	180,075 +124,287	+223%	+$12.6M	0.29%	39
2025 Q1	$5.63M	Buy	55,788 +53,177	+2,037%	+$5.35M	0.1%	118
2024 Q4	$233K	Sell	2,611 -161,675	-98%	-$14.2M	﹤0.01%	1028
2024 Q3	$13.8M	Sell	164,286 -14,850	-8%	-$1.17M	0.24%	55
2024 Q2	$13.8M	Buy	+179,136	New	+$13.1M	0.3%	38
2022 Q3	–	Sell	-49,731	Closed	-$1.85M	–	1076
2022 Q2	$1.85M	Buy	49,731 +41,026	+471%	+$1.67M	0.08%	224
2022 Q1	$385K	Buy	+8,705	New	+$377K	0.01%	647

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Graham Capital Management's BSX Position: Q1 2026 in Review

Graham Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 25,561 shares — an estimated $2.44M sold.

Graham Capital Management first reported a position in BSX in Q1 2022 and held it in 9 quarters. The position peaked at $19.3M in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Graham Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Graham Capital Management sold 25,561 Boston Scientific shares in Q1 2026, an estimated $2.44M.
Graham Capital Management first reported a position in Boston Scientific in Q1 2022 and held it in 9 quarters.
Graham Capital Management's Boston Scientific position peaked at $19.3M in Q2 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.